Stijn Laps

Title: Innovations in Crystallization: The Journey of Inventor Stijn Laps

Introduction

Stijn Laps, an accomplished inventor based in Beerse, Belgium, has made significant contributions to the field of pharmaceuticals. Working at Janssen Pharmaceutica NV, he has focused on developing innovative solutions that enhance the efficacy of drug formulations.

Latest Patents

Stijn Laps holds a noteworthy patent titled "Crystallization procedure for obtaining canagliflozin hemihydrate crystals." This invention relates to an improved crystallization process that allows for the production of canagliflozin hemihydrate crystals with a narrow particle size distribution. The procedure enhances the quality of the crystals by removing a small part of the crystalline suspension from the crystallization vessel, subjecting it to particle size reduction, and then reintroducing it into the vessel under carefully controlled temperature conditions.

Career Highlights

Throughout his career at Janssen Pharmaceutica NV, Stijn has demonstrated a commitment to innovation in pharmaceutical development. His work on crystallization processes has the potential to improve drug delivery and efficacy, showcasing his ability to bridge the gap between scientific research and practical application.

Collaborations

Stijn Laps collaborates with talented colleagues, including Ruben De Keyser and Thomas Joachim Landewald Rammeloo. These collaborations are vital in fostering a creative and productive work environment, leading to advancements in pharmaceutical technology.

Conclusion

As an inventor, Stijn Laps exemplifies the spirit of innovation in the pharmaceutical industry. His patent for an improved crystallization procedure underscores the importance of research and development in creating effective therapies. With continued collaboration and a focus on inventive solutions, he is poised to contribute further to the advancement of pharmaceutical sciences.